loading
前日終値:
$158.06
開ける:
$156.94
24時間の取引高:
1.08M
Relative Volume:
1.05
時価総額:
$7.96B
収益:
$4.06B
当期純損益:
$413.08M
株価収益率:
19.42
EPS:
8.01
ネットキャッシュフロー:
$560.48M
1週間 パフォーマンス:
-7.01%
1か月 パフォーマンス:
-5.66%
6か月 パフォーマンス:
-21.56%
1年 パフォーマンス:
-42.59%
1日の値動き範囲:
Value
$154.77
$158.71
1週間の範囲:
Value
$154.77
$169.26
52週間の値動き範囲:
Value
$150.79
$273.31

Charles River Laboratories International Inc Stock (CRL) Company Profile

Name
名前
Charles River Laboratories International Inc
Name
セクター
Healthcare (1166)
Name
電話
781-222-6000
Name
住所
251 BALLARDVALE ST, WILMINGTON, MA
Name
職員
20,100
Name
Twitter
@criverlabs
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
CRL's Discussions on Twitter

CRL を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Diagnostics & Research icon
CRL
Charles River Laboratories International Inc
155.55 7.96B 4.06B 413.08M 560.48M 8.01
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
500.16 196.14B 42.88B 6.34B 7.27B 16.53
Diagnostics & Research icon
DHR
Danaher Corp
205.85 150.17B 23.88B 3.90B 5.30B 5.28
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
415.87 34.36B 3.90B 887.87M 798.08M 10.67
Diagnostics & Research icon
A
Agilent Technologies Inc
116.69 33.28B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
177.39 31.62B 15.41B 1.37B 2.11B 7.50

Charles River Laboratories International Inc Stock (CRL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-03-21 ダウングレード Goldman Buy → Neutral
2025-03-04 アップグレード Citigroup Sell → Neutral
2025-03-03 アップグレード Redburn Atlantic Sell → Neutral
2025-01-22 ダウングレード William Blair Outperform → Mkt Perform
2025-01-17 ダウングレード UBS Buy → Neutral
2024-11-18 ダウングレード CLSA Hold → Underperform
2024-11-07 アップグレード CLSA Underperform → Hold
2024-10-23 開始されました CLSA Underperform
2024-10-14 開始されました Redburn Atlantic Sell
2024-10-07 ダウングレード Evercore ISI Outperform → In-line
2024-10-02 ダウングレード BofA Securities Buy → Neutral
2024-10-01 ダウングレード Citigroup Neutral → Sell
2024-08-08 ダウングレード JP Morgan Overweight → Neutral
2024-08-08 ダウングレード Robert W. Baird Outperform → Neutral
2024-06-28 ダウングレード Argus Buy → Hold
2024-06-07 開始されました Mizuho Neutral
2024-06-06 開始されました Goldman Buy
2024-02-15 ダウングレード Guggenheim Buy → Neutral
2023-09-13 開始されました TD Cowen Market Perform
2023-07-10 ダウングレード Citigroup Buy → Neutral
2023-02-23 アップグレード Guggenheim Neutral → Buy
2023-01-12 ダウングレード Jefferies Buy → Hold
2022-09-30 アップグレード Jefferies Hold → Buy
2022-08-25 開始されました Credit Suisse Outperform
2022-08-04 ダウングレード Morgan Stanley Overweight → Equal-Weight
2022-05-24 開始されました Guggenheim Neutral
2022-04-25 ダウングレード Jefferies Buy → Hold
2022-04-07 開始されました Stephens Overweight
2022-02-17 繰り返されました BofA Securities Buy
2022-02-17 アップグレード Citigroup Neutral → Buy
2022-02-17 繰り返されました Deutsche Bank Buy
2022-02-17 繰り返されました Morgan Stanley Overweight
2022-02-17 繰り返されました UBS Buy
2021-08-05 再開されました Credit Suisse Neutral
2020-12-16 ダウングレード Citigroup Buy → Neutral
2020-09-10 アップグレード Jefferies Hold → Buy
2020-07-01 アップグレード BofA Securities Neutral → Buy
2020-05-13 アップグレード UBS Neutral → Buy
2020-04-21 ダウングレード Jefferies Buy → Hold
2020-03-27 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-03-02 開始されました Deutsche Bank Buy
2020-02-18 アップグレード Wolfe Research Peer Perform → Outperform
2020-01-10 アップグレード Goldman Neutral → Buy
2020-01-08 開始されました Wells Fargo Overweight
2020-01-07 開始されました Citigroup Buy
2019-10-18 ダウングレード BofA/Merrill Buy → Neutral
2019-06-10 開始されました SVB Leerink Outperform
2019-04-30 再開されました Evercore ISI Outperform
2018-12-14 開始されました Deutsche Bank Buy
2018-10-09 開始されました UBS Neutral
2018-08-23 アップグレード Raymond James Mkt Perform → Outperform
2018-07-17 アップグレード RBC Capital Mkts Sector Perform → Outperform
2018-06-15 アップグレード KeyBanc Capital Mkts Sector Weight → Overweight
2018-02-14 アップグレード SunTrust Hold → Buy
すべてを表示

Charles River Laboratories International Inc (CRL) 最新ニュース

pulisher
Mar 27, 2025

Genetic Toxicology Testing Market To Witness Huge Gains Over - openPR

Mar 27, 2025
pulisher
Mar 27, 2025

Biopharma Layoffs Roundup - Contract Pharma

Mar 27, 2025
pulisher
Mar 26, 2025

Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery Platform - BioSpace

Mar 26, 2025
pulisher
Mar 25, 2025

Charles River Laboratories International Inc. stock underperforms Tuesday when compared to competitors - MSN

Mar 25, 2025
pulisher
Mar 25, 2025

Charles River, Valo Health Identify First Lupus Treatment Candidate Using Logica AI Platform - Marketscreener.com

Mar 25, 2025
pulisher
Mar 25, 2025

Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica - Business Wire

Mar 25, 2025
pulisher
Mar 24, 2025

Why Charles River Laboratories International, Inc. (CRL) is Among the Best Diagnostics Stocks to Invest in Right Now - Insider Monkey

Mar 24, 2025
pulisher
Mar 23, 2025

12 Best Diagnostics Stocks to Invest In Right Now - Insider Monkey

Mar 23, 2025
pulisher
Mar 21, 2025

Goldman Sachs Downgrades Charles River Laboratories International (CRL) - MSN

Mar 21, 2025
pulisher
Mar 21, 2025

Demystifying Charles River: Insights From 10 Analyst Reviews - Benzinga

Mar 21, 2025
pulisher
Mar 21, 2025

Icon stock, Charles River stock downgraded at Goldman (CRL) - Seeking Alpha

Mar 21, 2025
pulisher
Mar 21, 2025

Charles River (CRL) Up 1.9% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Mar 21, 2025
pulisher
Mar 21, 2025

This FedEx Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday - Benzinga India

Mar 21, 2025
pulisher
Mar 21, 2025

Goldman Sachs cuts Charles River Labs stock rating, target to $170 - Investing.com India

Mar 21, 2025
pulisher
Mar 21, 2025

Goldman Sachs cuts Charles River Labs stock rating, target to $170 By Investing.com - Investing.com South Africa

Mar 21, 2025
pulisher
Mar 21, 2025

Goldman Sachs Downgrades Charles River Laboratories International to Neutral From Buy, Adjusts Price Target to $170 From $190 - Marketscreener.com

Mar 21, 2025
pulisher
Mar 20, 2025

Jefferies maintains Charles River Labs stock hold, price target at $169 - Investing.com Canada

Mar 20, 2025
pulisher
Mar 20, 2025

Charles River Laboratories International Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Mar 20, 2025
pulisher
Mar 20, 2025

Interesting CRL Put And Call Options For November 21st - Nasdaq

Mar 20, 2025
pulisher
Mar 18, 2025

Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Recent Stock Performance Influenced By Its Fundamentals In Any Way? - Yahoo Finance

Mar 18, 2025
pulisher
Mar 13, 2025

Earnings call transcript: Charles River Labs beats Q4 2024 forecasts By Investing.com - Investing.com UK

Mar 13, 2025
pulisher
Mar 13, 2025

Should You Investigate Charles River Laboratories International, Inc. (NYSE:CRL) At US$171? - Simply Wall St

Mar 13, 2025
pulisher
Mar 11, 2025

Charles River Laboratories to Present at Barclays Global Healthcare Conference - BioSpace

Mar 11, 2025
pulisher
Mar 11, 2025

Molecular Breeding Market Insights, Competitive Intelligence and Growth Forecast 2025-2030 - GlobeNewswire Inc.

Mar 11, 2025
pulisher
Mar 10, 2025

Mutual of America Capital Management LLC Lowers Position in Charles River Laboratories International, Inc. (NYSE:CRL) - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

Smartleaf Asset Management LLC Increases Position in Charles River Laboratories International, Inc. (NYSE:CRL) - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Fairjourney Biologics acquires Charles River Laboratories South San Francisco facility - MSN

Mar 08, 2025
pulisher
Mar 08, 2025

Charles River Laboratories International, Inc. (NYSE:CRL) Q4 2024 Earnings Call Transcript - MSN

Mar 08, 2025
pulisher
Mar 08, 2025

Charles River, LabCorp upgraded, Quest downgraded at Citi on valuation - MSN

Mar 08, 2025
pulisher
Mar 07, 2025

Charles River announces agreement with Singapore General Hospital - SelectScience

Mar 07, 2025
pulisher
Mar 06, 2025

Charles River Laboratories International (NYSE:CRL) Stock Rating Upgraded by Citigroup - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Global Cell and Gene Therapy Manufacturing Market to Reach ~USD 10 Billion by 2032 | DelveInsight - GlobeNewswire Inc.

Mar 05, 2025
pulisher
Mar 04, 2025

Charles River Laboratories Shares Rise After Citigroup Upgrade -March 04, 2025 at 02:53 pm EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Citi raises Charles River stock rating, lifts target to $175 - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

Citi raises Charles River stock rating, lifts target to $175 By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

Citigroup Upgrades Charles River Laboratories International to Neutral From Sell, Adjusts Price Target to $175 From $155 - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

FairJourney Biologics Acquires Charles River Laboratories South San Francisco Facility - Joplin Globe

Mar 04, 2025
pulisher
Mar 04, 2025

Charles River Laboratories International, Inc. (NYSE:CRL) Receives Average Rating of “Reduce” from Brokerages - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Charles River Laboratories International (NYSE:CRL) Rating Increased to Neutral at Redburn Atlantic - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

Pricing woes and policy shifts shape Charles River’s 2025 outlook - BioProcess Insider

Mar 03, 2025
pulisher
Mar 03, 2025

High-Throughput Screening Technology Analysis and Global - GlobeNewswire

Mar 03, 2025
pulisher
Mar 03, 2025

Redburn raises Charles River Labs stock to neutral, ups target to $188 - Investing.com Australia

Mar 03, 2025
pulisher
Mar 03, 2025

Redburn Atlantic Upgrades Charles River Laboratories International to Neutral From Sell, Adjusts PT to $188 From $171 - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

Redburn raises Charles River Labs stock to neutral, ups target to $188 By Investing.com - Investing.com South Africa

Mar 03, 2025
pulisher
Mar 01, 2025

Anchor Capital Advisors LLC Reduces Position in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Advisor OS LLC - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

Principal Financial Group Inc. Sells 1,306 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) - Defense World

Mar 01, 2025
pulisher
Feb 28, 2025

Bell Global Equities Sold Charles River Laboratories International (CRL) Due To Its Potential For On-going Risk To Earnings - Insider Monkey

Feb 28, 2025

Charles River Laboratories International Inc (CRL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
diagnostics_research DGX
$167.33
price up icon 0.80%
diagnostics_research LH
$230.02
price down icon 0.71%
$143.94
price down icon 2.94%
diagnostics_research WAT
$362.16
price down icon 2.27%
diagnostics_research MTD
$1,177.09
price down icon 1.36%
diagnostics_research IQV
$177.39
price down icon 1.10%
大文字化:     |  ボリューム (24 時間):